BioPharma Resources

Drugs by condition

Drugs approved for copd

Brand-name prescription drugs and biologics whose FDA label lists copd as an approved use. Matched on the label phrases: "chronic obstructive pulmonary disease", "COPD".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

27

Still marketed, NDA or BLA

Drug classes

8

Novel drugs

12

New molecular entities and new biologics

In development

40+

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for copd.

  • Ohtuvayre (Ensifentrine) · Msd NovelJun 26, 2024
  • Nucala (Mepolizumab) · Glaxosmithkline OrphanJun 6, 2019
  • Yupelri (Revefenacin) · Mylan Ireland LTD NovelNov 9, 2018
  • Trelegy Ellipta (Fluticasone Furoate, Umeclidinium Bromide, Vilanterol Trifenatate) · Glaxosmithkline Sep 18, 2017
  • Dupixent (Dupilumab) · Regeneron Pharmaceuticals NovelBreakthrough therapyPriority reviewOrphanMar 28, 2017

All approved drugs for copd, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 61 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Interleukin-5 Antagonist (2)

  • Nucala Mepolizumab · Glaxosmithkline LLC · 2015
  • Nucala Mepolizumab · Glaxosmithkline · 2019

Phosphodiesterase 3 Inhibitor (1)

Anticholinergic (1)

  • Yupelri Revefenacin · Mylan Ireland LTD · 2018

Interleukin-4 Receptor alpha Antagonist (1)

  • Dupixent Dupilumab · Regeneron Pharmaceuticals · 2017

Phosphodiesterase 4 Inhibitor (1)

  • Daliresp Roflumilast · Astrazeneca · 2011

Neuraminidase Inhibitor (1)

  • Relenza Zanamivir · Glaxosmithkline · 1999

Corticosteroid (1)

  • Symbicort Budesonide, Formoterol Fumarate Dihydrate · Astrazeneca · 2006

Class not listed in FDA's data (19)

  • Striverdi Respimat Olodaterol Hydrochloride · Boehringer Ingelheim · 2014
  • Anoro Ellipta Umeclidinium Bromide, Vilanterol Trifenatate · Glaxosmithkline · 2013
  • Breo Ellipta Fluticasone Furoate, Vilanterol Trifenatate · Glaxo Grp LTD · 2013
  • Tudorza Pressair Aclidinium Bromide · Azurity · 2012
  • Spiriva Tiotropium Bromide · Boehringer Ingelheim · 2004
  • Dopram Doxapram Hydrochloride · Hikma · 1965
  • Trelegy Ellipta Fluticasone Furoate, Umeclidinium Bromide, Vilanterol Trifenatate · Glaxosmithkline · 2017
  • Bevespi Aerosphere Formoterol Fumarate, Glycopyrrolate · Astrazeneca · 2016
  • Spiriva Respimat Tiotropium Bromide · Boehringer Ingelheim · 2015
  • Stiolto Respimat Olodaterol Hydrochloride, Tiotropium Bromide · Boehringer Ingelheim · 2015
  • Spiriva Respimat Tiotropium Bromide · Boehringer Ingelheim · 2014
  • Incruse Ellipta Umeclidinium Bromide · Glaxo Grp England · 2014
  • Combivent Respimat Albuterol Sulfate, Ipratropium Bromide · Boehringer Ingelheim · 2011
  • Perforomist Formoterol Fumarate · Viatris Specialty · 2007
  • Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
  • Atrovent Hfa Ipratropium Bromide · Boehringer Ingelheim · 2004
  • Advair Diskus 500/50 Fluticasone Propionate, Salmeterol Xinafoate · Glaxo Grp LTD · 2000
  • Serevent Salmeterol Xinafoate · Glaxosmithkline · 1997
  • Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986

Drugs in development for copd

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • ItepekimabREGN3500, SAR440340Phase 39 trials

    Sanofi · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Bronchiectasis

  • LunsekimigSAR443765Phase 39 trials

    Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • PF-07275315tilrekimigPhase 38 trials

    Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease

  • TozorakimabMEDI3506Phase 36 trials

    AstraZeneca · Chronic Obstructive Pulmonary Disease (COPD), Asthma, Viral Lung Infection and Acute Respiratory Failure

  • CM310Phase 35 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease

  • TQC2731Phase 35 trials

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

  • Hemay005Mufemilast, Phosphodiesterase 4 inhibitorsPhase 34 trials

    Ganzhou Hemay Pharmaceutical Co., Ltd · Moderate to Severe Ulcerative Colitis, Ulcerative Colitis (UC), COPD (Chronic Obstructive Pulmonary Disease)

  • HSK39004 DryPhase 34 trials

    Haisco Pharmaceutical Group Co., Ltd. · Chronic Obstructive Lung Disease (COLD), COPD (Chronic Obstructive Pulmonary Disease), Chronic Obstructive Pulmonary Disease (COPD)

  • VerducatibBI 1291583Phase 34 trials

    Boehringer Ingelheim · Bronchiectasis, Chronic Obstructive Pulmonary Disease

  • AstegolimabPhase 33 trials

    Roche (Genentech) · Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD)

  • BGF MDI 320BGFPhase 33 trials

    AstraZeneca · Asthma, COPD (Chronic Obstructive Pulmonary Disease)

  • CM326Phase 33 trials

    CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Moderate to Severe Asthma

  • HSK31858Phase 33 trials

    Haisco Pharmaceutical Group Co., Ltd. · Non-cystic Fibrosis Bronchiectasis, Asthma Bronchiale, Bronchiectasis

  • RLS-0071Phase 33 trials

    ReAlta Life Sciences, Inc. · Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Hypoxic-Ischemic Encephalopathy, Steroid Refractory GVHD

  • TQC3721 forPhase 33 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Obstructive Pulmonary Disease, Pulmonary Disease, Chronic Obstructive

  • Areteia Therapeutics · Chronic Obstructive Pulmonary Disease, Eosinophilic Asthma, Asthma; Eosinophilic

  • HSK39004 Dry SimulantPhase 32 trials

    Haisco Pharmaceutical Group Co., Ltd. · COPD (Chronic Obstructive Pulmonary Disease), Chronic Obstructive Pulmonary Disease (COPD)

  • REGEND001Phase 32 trials

    Regend Therapeutics · COPD (Chronic Obstructive Pulmonary Disease), Idiopathic Pulmonary Fibrosis

  • JKN2401Phase 31 trial

    Joincare Pharmaceutical Group Industry Co., Ltd · Chronic Obstructive Pulmonary Disease (COPD)

1 discontinued brand-name drugs whose label still names it

More on copd: recruiting trials · published research

Related in respiratory: Pulmonary arterial hypertension · Asthma · Cystic fibrosis · Idiopathic pulmonary fibrosis · Allergies (allergic rhinitis)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.